U.S. markets close in 2 hours 39 minutes
  • S&P 500

    4,122.14
    -17.92 (-0.43%)
     
  • Dow 30

    32,821.96
    -10.58 (-0.03%)
     
  • Nasdaq

    12,468.42
    -176.04 (-1.39%)
     
  • Russell 2000

    1,908.85
    -32.35 (-1.67%)
     
  • Crude Oil

    90.07
    -0.69 (-0.76%)
     
  • Gold

    1,812.70
    +7.50 (+0.42%)
     
  • Silver

    20.50
    -0.12 (-0.58%)
     
  • EUR/USD

    1.0220
    +0.0025 (+0.25%)
     
  • 10-Yr Bond

    2.7860
    +0.0210 (+0.76%)
     
  • GBP/USD

    1.2082
    +0.0000 (+0.00%)
     
  • USD/JPY

    135.0660
    +0.0930 (+0.07%)
     
  • BTC-USD

    23,098.82
    -868.36 (-3.62%)
     
  • CMC Crypto 200

    536.86
    -20.49 (-3.68%)
     
  • FTSE 100

    7,488.15
    +5.78 (+0.08%)
     
  • Nikkei 225

    27,999.96
    -249.28 (-0.88%)
     

Recap: Inogen Q2 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 73.33% over the past year to $0.12, which beat the estimate of ($0.06).

Revenue of $71,691,000 declined by 29.06% from the same period last year, which missed the estimate of $79,960,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Inogen hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Aug 04, 2020

View more earnings on INGN

Time: 04:30 PM

ET Webcast URL: https://investor.inogen.com/news-events/ir-calendar

Recent Stock Performance

Company's 52-week high was at $76.89

Company's 52-week low was at $29.28

Price action over last quarter: down 22.44%

Company Profile

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.